Take 2 capsules once daily.
If things go very well, it might be approved for obesity in mid-2026, but it might take a little bit longer for it to be approved for cardiovascular risk reduction. Beware Grey Market Dupes If you just re-read the abovethat reta wont be available for a whileand are scratching your head because you have a friend who says theyre taking it or youve seen ads online for it, keep in mind that theyre not getting an approved drug at a pharmacy
PMID: 86 OuyangA.ChenT.FengY.ZouJ.TuS.JiangM.et al
GLP-1 receptor agonists should only be continued if there is a beneficial metabolic response, defined as a reduction of at least 11 mmol/mol (1.0%) in HbA1c and a weight loss of at least 3% of initial body weight at six months
It is up to each insurer and its chief medical officer to decide if these medications will be covered
Blood Flow Improvements Through a vascular hypometabolism lens, GLP-1s are not merely weight-loss or glucose-lowering drugs, they are neuro-metabolic stabilizers